Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPoster Presentations - Physicians/Scientists/Pharmacists

Optimization and stability studies of thymidine analog complex with organometallic core

Rodrigo Santos, Bluma Faintuch, Rodrigo Teodoro, Ivane Nunes and Roger Schibli
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 526P;
Rodrigo Santos
1Radiopharmacy Center, Institute of Energy and Nuclear Research, Sao Paulo, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bluma Faintuch
1Radiopharmacy Center, Institute of Energy and Nuclear Research, Sao Paulo, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodrigo Teodoro
1Radiopharmacy Center, Institute of Energy and Nuclear Research, Sao Paulo, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivane Nunes
1Radiopharmacy Center, Institute of Energy and Nuclear Research, Sao Paulo, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Schibli
2Center of Radiopharmacy, Paul Scherrer Institute, Villigen, ZU, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1913

Objectives: Radiolabeled thymidine analogs can be used to track rapidly proliferating tumor cells . For the current study thymidine was functionalized at the C5’position of the sugar moiety with the tridentate iminodiacetic acid chelator for complexation and radiolabeling with 99mTc(I)-tricarbonyl core. The aims were optimization of the labeling procedure and analysis of stability of the radiolabeled compound.

Methods: The precursor 99mTc(H2O)3(CO)3 was prepared by flushing the mixture of sodium carbonate, sodium borohydride and sodium-potassium tartrate tetrahydrate with CO gas during 30 min. Pertechnetate was added and the vial was heated for 35 min at 75 oC. The reaction was stopped in ice bath, and pH was adjusted to 7. Then 50 uL of the precursor was added to 10-4 M of the ligand and heated again for 60 min at 75 oC. Radiochemical purity of the precursor and the product was checked by HPLC, TLC and paper chromatography. Optimization was achieved by varying reaction time (30 to 60 min),ligand concentration (0.5.10-4 to 2.5.10-4 Mol/L), final reaction volume (300 to 500 μL) and total activity(170 to 1330 MBq). Radiochemical stability (24 hours), in- vitro stability in human plasma, and response to cysteine challenge at different molar ratios was also evaluated.

Results: Radiochemical purity (RP) with reaction time of 30 minutes was 90.7 +/- 1.6%, and by one hour it reached 93.2+/-1.4 %, using a concentration of thymidine analog of 0.5.10-4 Mol/L.By increasing the ligand concentration to 2.5.10-4 Mol/L, 94.1+/-1.7% of RP was achieved. Reduction of final reaction volume or elevation of activity resulted in no improvement. The complex was stable for 24 hours with loss of 4% of RP only. Stability test in human plasma during 4 hours showed a decrease of 26%, and stability regarding cysteine from 0.1 mM to 100 mM diminished from 97.3+/- 0.5% to 88.7+/- 0.8%, respectively.

Conclusions: Favorable labeling conditions could be established, with relatively few changes when reaction parameters were modified. Radiochemical stability was excellent, but tests with plasma and cysteine yielded somewhat weaker results. Nevertheless, the final product is suitable for biological studies in vivo.

Research Support (if any): Aknowledgement:The valuable support of a MS scholarship from the National Research Council (CNPq), Brazil to Rodrigo Santos is appreciated.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 47, Issue suppl 1
May 1, 2006
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Optimization and stability studies of thymidine analog complex with organometallic core
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Optimization and stability studies of thymidine analog complex with organometallic core
Rodrigo Santos, Bluma Faintuch, Rodrigo Teodoro, Ivane Nunes, Roger Schibli
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 526P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Optimization and stability studies of thymidine analog complex with organometallic core
Rodrigo Santos, Bluma Faintuch, Rodrigo Teodoro, Ivane Nunes, Roger Schibli
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 526P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster Presentations - Physicians/Scientists/Pharmacists

  • Early prediction of response to chemotherapy using FDG PET/CT in advanced/metastatic non-small cell lung cancer
  • L1-Targeted Cu-67-radioimmunotherapy in combination with immunotherapy for treatment of ovarian cancer metastases
  • PET tumor volume assessment with different CT patient positions in lung cancer
Show more Poster Presentations - Physicians/Scientists/Pharmacists

Radiopharmaceutical Chemistry Track

  • Preparation of high specific activity Fluorine-18 nanoparticles using click chemistry
  • Biodistribution of radiolabeled, monoclonal antibody (MoAb)-conjugated peptidomimetic antagonists to access status of tumor angiogenesis via selective targeting of αvβ3 receptors
  • Topo-II activity and tumor cell uptake studies of the 64Cu-4N-azabicyclo[3,2,2]nonane TSC complexes targeted at topoisomerase-II
Show more Radiopharmaceutical Chemistry Track

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire